The rationale behind this combination is that, besides promoting angiogenesis, VEGF plays a part in immunity by enhancing the number of Treg cells and MDSCs in the tumor while reducing the intratumoral influx of lymphocytes and suppressing DC maturation. The gene discussed is VEGFA; the disease is neoplasm.